The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.
 
Eric Baudin
Honoraria - Ipsen (Inst); Novartis (Inst)
Speakers' Bureau - Advanced Accelerator Applications; HRA Pharma; Ipsen
 
Alfredo Berruti
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi; Sanofi
 
Mario Giuliano
Speakers' Bureau - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Roche
 
Wasat Mansoor
Consulting or Advisory Role - Bristol-Myers Squibb; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; SERVIER
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Catalin Bobirca
Employment - Novartis (I)
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Erik Houtsma
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Niamh Fagan
Employment - Novartis
 
Kjell E. Oberg
No Relationships to Disclose
 
Piero Ferolla
Consulting or Advisory Role - Ipsen; Merck Serono; Novartis
Speakers' Bureau - Ipsen; Merck Serono; Novartis
Research Funding - Ipsen; Merck Serono; Novartis
Travel, Accommodations, Expenses - Ipsen; Merck Serono; Novartis